BIA Assessment of Polymyoneuropathy in Critically Ill Patients

Launched by UNIVERSITY HOSPITAL OSTRAVA · Feb 12, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how critically ill patients, who are on artificial ventilation for at least a week, experience changes in their body composition, especially muscle mass. The focus is on patients with serious conditions like sepsis, trauma, or respiratory issues. Researchers want to see how a special care package, which includes nutritional advice and a physiotherapy plan, compares to standard care in helping patients recover over 12 weeks after their time in the Intensive Care Unit (ICU).

To be eligible for the trial, participants should be adults aged 65 or older who have respiratory problems and are expected to need ventilation for at least seven days. Patients must also provide consent, which can be done by a witness if they are unable to sign themselves. However, those with very serious health issues, such as severe brain injuries or certain types of cancer, may not be able to participate. If you join the study, you can expect close monitoring of your recovery and support aimed at improving your overall health after a critical illness.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with respiratory insufficiency
• • Expected period of artificial ventilation of 7 days
• • Acute lung injury (ALI)
• • Acute respiratory distress syndrome (ARDS)
• • Acute exacerbation of chronic obstructive pulmonary disease (COPD)
• • Signed informed consent (may be signed by witnesses, if the patient is unconscious)
• Exclusion Criteria:
• • Patients with unfavorable prognosis for 12-week follow-up
• • APACHE Score \>30
• • Metastasizing malignity
• • Patients after cardiopulmonary resuscitation (CPR) prior to admission
• • Cerebral edema
• • Cerebral trauma
• • Intracranial hypertension
• • Liver cirrhosis